WADA Releases 2026 Annual Report: More Samples Tested, But Growth Is Slowing Down

In my spreadsheet, the latest row on global anti-doping sample testing has just been filled in: 297,965. That is the figure for 2026, published in the 2026 annual report of the World Anti-Doping Agency (WADA). I enter the number first and read the commentary afterwards, because my professional habit has taught me that the prose is always more optimistic than the figures. The report's headline speaks of WADA increasing its testing volume. That is true — but only half true. I sat with the data for about two hours. In 2026, the system processed 288,865 samples. In 2026, the figure was 297,965. The difference is roughly 9,100 samples. Read those two numbers alone and the story is of a machine expanding. But read two more — growth of 12.5% across 2026-2026 and 3.2% across 2026-2026 — and the story flips entirely. The curve is bending sideways, not climbing. Numbers do not lie, but they know how to hide something. WADA was founded in 2026 and is headquartered in Montreal, Canada, acting as the coordinating body for anti-doping rules across the entire global sports system. Its annual report is not a results table for a competition but an operational audit: how many samples were collected, how many returned adverse findings, how many countries were judged non-compliant, how money flowed in and out, and when the next set of rules takes effect. For someone who reads numbers for a living, this is the driest and most worthwhile document of the year. The data series WADA publishes stretches from 2026 to 2026, seven consecutive years. I value the maintenance of such a long series because it allows signal to be separated from noise. A single figure can be an administrative error. Seven consecutive years becomes a trend. One technical detail is easy to misread: the report carries a 2026 label, but most testing data reflects activity in 2026 and 2026, following the convention of a one-year publication lag. Anyone citing this document should state the timeframe clearly, otherwise figures from an old year get attributed to a new one. For those who follow swimming, this report matters more than it appears. Swimming is one of the most sample-intensive sports in the Olympic system, given the large number of events, the size of the athlete pool, and the fact that its distances require continuous out-of-competition testing. In other words, the quality of the sample-collection machinery directly determines how much fairness a swimmer feels on the lane line. A weakened collection system does not falsely catch anyone, but it steadily erodes the clean athlete's confidence. The most stable data point in the entire report is also the least discussed. The Adverse Analytical Finding (AAF) rate over three years was 0.77%, 0.80% and 0.78% respectively. The swing is only about 0.03 percentage points. In a system where sample volume grew by nearly nine thousand units, a detection rate that stays put is a weighty piece of information. It can mean two things. First, the actual prevalence of doping in sport is stable. Second, the system is widening its net but still pulling in a population with the same probability of testing positive. The data alone cannot distinguish these two possibilities. An AAF rate is not a number; it is a confession — a confession that we know what we are measuring, but not necessarily what we are missing. The athlete-consultation section records more than 600 athletes and commission representatives from more than 60 countries and more than 70 sports. This is an effort to build legitimacy for the new rules, and I note it as a procedural step forward. But the limit must be stated plainly: the report offers no measure showing that athlete input actually changed the substance of the code. The number of people consulted is not the same as the number of clauses amended. This is the kind of data I always separate from the conclusion. The compliance-audit section is where I lingered longest. Average non-conformities fell from 25.5 to 20 — a significant improvement if you look only at the number. But that number comes from just nine audits. Nine observations is a thin evidence base: enough to suggest, not enough to conclude. And within that error pool, one counter-current detail emerges: non-conformities related to sample collection rose 11%, accounting for 45% of all findings, with 23% classified as critical. That means the inspection apparatus is improving on paper while field collection shows signs of deterioration. For a national agency short on staff, this is the first point of collapse. Alongside that, WADA records more than 250 investigative operations, 88 laboratories dismantled and more than 90 tonnes of materials seized. This is the clearest strategic pivot in the report: from traditional sample collection toward investigation and prevention. Technically, this direction is more cost-effective per detection, because it targets production and distribution networks rather than individual athletes alone. But it also creates a shift worth tracking: as resources are pulled toward investigation, routine collection comes under corresponding pressure. The financial section is where the system's strain is most visible. The budget recorded a shortfall of 8.3 million USD against plan. Of that, the United States has not paid 3.8 million USD and Russia still owes 3.9 million USD. At the same time, the report still records a net surplus of 1.2 million USD. Placed side by side, these two facts produce an odd picture: the agency is tightening spending while two major contributions hang in the air. For an organisation whose entire authority derives from operational capability, cash flow is not merely accounting. It is enforcement capability. The 2027 World Anti-Doping Code was adopted in Busan, South Korea, and takes effect on 1 January 2027. This is a fixed, plannable milestone, and the single most valuable item in the entire report for any federation. But precisely because it is fixed, the period from now to that date becomes a compliance gap: the new rules have been issued but are not yet in force, and old behaviour can persist in between. Here I have to say plainly what the report's headline does not. The most worrying thing in this document is not the number of samples, but who will pay to sustain that number. An anti-doping organisation can live with a flat detection rate. It cannot live with a budget suspended by the political decisions of major contributing states. And this is where I go against the common reading. Most will look at the 250 investigative operations and 90 tonnes seized and call it an achievement. That reading is not wrong, but it overlooks an operational reality: investigation is a targeted activity, while routine collection is an insurance activity. A swimmer in a country with a weak testing system will not be protected by any laboratory raid on another continent. Their confidence depends on whether anyone knocks on their door at six in the morning. My experience following swim meets shows something simple: doping cases in swimming almost never break from a single test. They break from a data series accumulated long enough to reveal an anomaly. That series only exists if someone collects samples regularly, correctly and at the right moment. Two thousand four hundred Serie A matches, and one evening I realised I was watching the pulse of an entire football culture — but here, that pulse sits inside a collection procedure, not inside a results table. WADA deserves fairness on one point. If major contributions remain suspended for years, the rational organisational response is not to spread samples evenly across all sports but to concentrate resources where detection probability is highest. That strategy is efficient on paper, yet it produces a consequence nobody wants to publicise: lower-risk sports, swimming among them, may see reduced out-of-competition testing frequency. No announcement is made about it. It simply shows up, gradually, in the data tables of later years. Emotion is the most expensive thing on the market, and in the anti-doping story it is also the easiest thing to swap out. A report headlined around increasing tests is easily read as an entirely positive signal. But the data inside tells a two-sided story: greater volume, slower growth, a flat detection rate, deteriorating collection procedures and suspended funding. So what signals should be tracked in the next cycle? First, the sample-volume growth rate in the next report — if it flattens or turns negative, that is genuine capacity erosion rather than speed adjustment. Second, the AAF rate — if it breaks above 0.85%, the question shifts from whether the system is finding the right people to whether reality is changing. Third, the share of collection-procedure non-conformities in compliance audits — the current 45% is a starting point, not an endpoint. Fourth, the contribution status of the United States and Russia, because that variable determines everything else. For someone who reads tables for a living, this year's report offers no conclusion. It offers a curve that is bending sideways, along with an unanswered question: can a system keep widening its testing net while the resources that sustain that net are suspended by decisions beyond its own control? Football stopped moving, but thousands of samples still whisper in my spreadsheet.